Black men with metastatic hormone-sensitive prostate cancer may have better outcomes if they receive enzalutamide rather than bicalutamide in combination with androgen deprivation therapy, data from a phase 2 trial suggests.
Nearly a million more Black adults in the United States would have stage 3 chronic kidney disease if the race coefficient were removed from the CKD-EPI equation used to estimate glomerular filtration rate, according to an analysis.
Removing the race coefficient from the CKD-EPI equation could avert a potential systematic delay in kidney transplant eligibility of a median 1.9 years for Black patients, according to investigators.
Mistrust and concerns about masculinity are important factors that influence Black men’s experience during prostate cancer management.
Bias extends beyond skin color to the assumptions physicians might make about patients.
Missed appointments and other impediments to continuity of care are among the major challenges urologists report when managing poverty-stricken men with prostate cancer.
Patients with prostate cancer who live in rural areas are less likely than their urban counterparts to receive treatment and make follow-up visits after RP.
Many are calling for standard dialysis coverage for undocumented immigrants with end-stage renal disease.
